UDF-11553-05552 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Registered in v-safe
2021-03-23
Dose 1 — Pfizer-BioNTech
2021-03-23
Health check-in — day 0, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-03-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-13
Dose 2 — Pfizer-BioNTech
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-07-13
Survey response — 3 months, dose 2
MedDRA: Ear infection, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Ear infection and upper respiratory infection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-22
Call 1 — Could Not Reach Participant
2021-07-22
Call successful
Other
2021-10-14
Survey response — 6 months, dose 2
MedDRA: Ear infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Ear infections

MedDRA releases: 2024-11 · check-in free text available
2021-10-14
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-18
Call 1 — Could Not Reach Participant
2022-04-13
Survey response — 12 months, dose 2
MedDRA: Ear disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Ear problems

MedDRA releases: 2024-11 · check-in free text available
2022-04-13
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Pfizer-BioNTech
2	2021-04-13	Pfizer-BioNTech

Call center

3 call center cases

1 successful · 2 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-13

Symptoms: Ear infection and upper respiratory infection

Release 10 — 6 months, dose 2

2021-10-14

Symptoms: Ear infections

Release 11 — 12 months, dose 2

2022-04-13

Symptoms: Ear problems

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ear disorder	·	·	✓
SD	Ear infection	✓	✓	✓
SD	Upper respiratory tract infection	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release